Literature DB >> 1155833

Effects of organic phosphate systemic insecticides on bovine embryonic survival and development.

R A Bellows, T S Rumsey, C W Kasson, J Bond, E J Warwick, O F Pahnish.   

Abstract

Experiments were conducted to determine effects of 2 organic phosphate systemic insecticides on embryonic survival and possible teratogenesis in cattle. A total of 726 heifers at 3 locations were treated with either crufomate (4-tert-butyl-2-chlorophenyl methyl methylphos-phoramidate) or coumaphos (O,O-diethyl O-(3-chloro-4-methyl-2-oxo-2H-1-benzopyran-7-yl) phosphorothioate). The compounds were administered to pregnant bovine females at various stages of gestation by pouring along the dorsal midline. None of the treatments, including those at recommended one-time doses, one-time doses at double or triple the recommended dose levels, or doses at recommended one-time dose levels repeated each day for 10 days, gave evidence of increasing embryonic death rates or of teratogenic effects. In one experiment, the crufomate compound had apparent erratic effects on serum ace5ylcholinesterase activities, but no effects on electrocardiographic patterns, heart rate, or respiration rate. Rectal palpation for pregnancy determination during the 35- to 44-day stages of pregnancy is discussed as a possible, but unsubstantiated, cause of congenital malformation of the caudal portion of the intestinal tract in 1 calf born during these studies and in other calves previously observed.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1155833

Source DB:  PubMed          Journal:  Am J Vet Res        ISSN: 0002-9645            Impact factor:   1.156


  1 in total

1.  Comparison between allantochorion membrane and amniotic sac detection by per rectal palpation for pregnancy diagnosis on pregnancy loss, calving rates, and abnormalities in newborn calves.

Authors:  Juan E Romano; Pablo Pinedo; Kelsey Bryan; Roney S Ramos; Karol G Solano; Daniel Merchan; Juan Velez
Journal:  Theriogenology       Date:  2016-11-12       Impact factor: 2.740

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.